Pacira BioSciences, Inc.

US$36.43As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PCRXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 1.37%
Div yield —
ROE 5.24%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM 39.91
TSR TTM 70.39%
Mkt cap US$1.461B
ROIC 6.28%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$41
12.33%
(55.51%)
Hold 1|3|12|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.41
0.41
0.45
0.48
23.37%
13.47%
18.63%
19.17%
Revenue$M
108.5
110.6
111.2
112.7
3.92%
2.16%
5.37%
1.14%
Peers (US$1.461B)
Cap (US$)
PE
1.428B
13.47x
1.450B
253.8x
Capital
TTM
5Y
10Y
Leveragex
0.392
—
—
EBIT/Intx
7.879
0.263
0.271
Own earn%
60.53
12.99
(7.34)
Sh yield%
40.63
25.73
27.21
Owners
Insiders/Inst%
10.19
47.10
Short interest%
4.51
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
9–20
$1 testx
—
Incr. ROIC%
0